CD44 and breast cancer: In addition, Bourguignon et al. showed that chemotherapy resistance in ovarian and breast cancer cells arises via the HA–CD44 interaction by inducing the binding of Ankyrin to MDR1 (Bourguignon et al. 2008, p 44).